Array Biopharma, Inc. (ARRY) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $8.54 --0%
EPS Growth %: -48.0%
Financial Fact:
Weighted average shares outstanding - diluted (in shares): 145.1M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -48.0%
Financial Fact:
Weighted average shares outstanding - diluted (in shares): 145.1M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Array Biopharma, Inc. (NASDAQ: ARRY) reported Q4 EPS of ($0.22), $0.01 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $6 million versus the consensus estimate of $8.1 million.
For earnings history and earnings-related data on Array Biopharma, Inc. (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA lists top 5 themes driving next $1tn in incremental semi sales
- OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates
- Sunstone Hotel Investors to sell Hyatt Regency San Francisco for $279M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
